7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $362M | -$257M | 73.4% | -114.1% | -$130M | $637M | $33M |
| 2024 | $799M | -$3M | 83.7% | -0.9% | -$35M | $487M | $41M |
| 2023 | $735M | -$63M | 78.4% | -11.1% | $95M | $498M | $91M |
| 2022 | $632M | -$149M | 70.3% | -50.4% | $47M | $510M | $16M |
| 2021 | $1.1B | -$189M | 77.5% | -46.1% | -$319M | $670M | $84M |
| 2020 | $877M | -$44M | 77.3% | -7.4% | -$129M | $401M | $144M |
| 2018 | $226M | $28M | 64.8% | 12.7% | -$727000 | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $12M | -$37M | 30.2% | -292.0% | $7M | $653M | $40M |
| Dec '25 | $13M | -$33M | 65.6% | -255.3% | -$39M | $637M | $33M |
| Sep '25 | $34M | -$166M | 41.2% | -842.2% | -$35M | $582M | $32M |
| Jun '25 | $94M | -$54M | 65.5% | -105.7% | -$41M | $560M | $36M |
| Mar '25 | $221M | -$4M | 82.2% | 3.0% | -$15M | $486M | $22M |
| Dec '24 | $389M | $26M | 86.6% | 20.6% | $12M | $487M | $41M |
| Sep '24 | $118M | $7M | 83.4% | -36.1% | -$16M | $481M | $36M |
| Jun '24 | $106M | -$26M | 80.5% | -38.4% | -$39M | $453M | $14M |
| Mar '24 | $186M | -$9M | 79.5% | -2.2% | $8M | $485M | $98M |
| Dec '23 | $277M | -$1M | 85.2% | 5.4% | $66M | $498M | $91M |
| Sep '23 | $132M | -$24M | 72.7% | -28.8% | $3M | $497M | $26M |
| Jun '23 | $143M | -$29M | 74.5% | -37.1% | $8M | $496M | $25M |
| Mar '23 | $183M | -$9M | 75.2% | -3.1% | $18M | $510M | $32M |
| Dec '22 | $69M | -$61M | 70.3% | -192.0% | -$42M | $510M | $16M |
| Sep '22 | $133M | -$30M | 63.9% | -44.4% | $93M | $666M | $215M |
| Jun '22 | $159M | -$44M | 67.8% | -63.7% | -$52M | $667M | $76M |
| Mar '22 | $271M | -$13M | 74.9% | -9.4% | $48M | $668M | $130M |
| Dec '21 | $450M | -$155M | 77.8% | -94.1% | -$227M | $670M | $84M |
| Sep '21 | $212M | -$20M | 74.7% | -23.0% | -$52M | $443M | $85M |
| Jun '21 | $197M | -$12M | 81.0% | -9.6% | -$68M | $419M | $113M |
How the market has priced GOCO against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, GoHealth, Inc.'s revenue has declined 16.2% per year. These are computed facts, not advice.
As of FY2025, GoHealth, Inc. reported $637M of total debt against $33M of cash; operating income covered interest expense -4.7×.
In FY2025, gross margin was 73.4%, operating margin -114.1%, and net margin -71.1%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.